[1]
K. M. Matsuda, “Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study”, acbr, vol. 5, no. 1, pp. 76–84, Jan. 2021.